Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Seyfried

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Frontiers in Oncology|May 17, 2024
Editorial: Reviews in hematologic malignancies: 2023Billy Michael Chelliah Jebaraj, Michael Liew, Felix Seyfried
Blood Advances|October 5, 2024
The dual BCL-2 and BCL-XL inhibitor AZD4320 acts on-target and synergizes with MCL-1 inhibition in B-cell precursor ALLMaren Christiane Wichert, Colin Fortner, Alexandra Niedermayer, et al.
Frontiers in Cell and Developmental Biology|September 27, 2021
MCL-1 Inhibition Overcomes Anti-apoptotic Adaptation to Targeted Therapies in B-Cell Precursor Acute Lymphoblastic LeukemiaAlbert Manzano-Muñoz, Clara Alcon, Pablo Menéndez, et al.
Leukemia|January 15, 2022
Synergistic activity of combined inhibition of anti-apoptotic molecules in B-cell precursor ALLFelix Seyfried, Felix Uli Stirnweiß, Alexandra Niedermayer, et al.
Cell Death & Disease|April 4, 2026
Therapeutic potential of BH3-mimetics and NK cell-mediated immunotherapy in T-ALLColin Fortner, Alexandra Niedermayer, Melina Maria Bäuerle, et al.
Haematologica|March 10, 2018
Leukemia reconstitution <i>in vivo</i> is driven by cells in early cell cycle and low metabolic stateLuca Trentin, Manon Queudeville, Sarah Mirjam Eckhoff, et al.
Leukemia|April 15, 2025
Remission induction in refractory, drug resistant pediatric PICALM::MLLT10+ B-cell acute lymphoblastic leukemia by venetoclaxAlexandra Niedermayer, Jana Stursberg, Anke Katharina Bergmann, et al.
Blood|April 7, 2018
Tight regulation of FOXO1 is essential for maintenance of B-cell precursor acute lymphoblastic leukemiaFan Wang, Salih Demir, Franziska Gehringer, et al.
Blood|May 28, 2017
Central nervous system involvement in acute lymphoblastic leukemia is mediated by vascular endothelial growth factorVera Münch, Luca Trentin, Julia Herzig, et al.
Cell Death & Disease|July 3, 2024
Venetoclax resistance in acute lymphoblastic leukemia is characterized by increased mitochondrial activity and can be overcome by co-targeting oxidative phosphorylationStefanie Enzenmüller, Alexandra Niedermayer, Felix Seyfried, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Frontiers in Oncology|May 17, 2024
Editorial: Reviews in hematologic malignancies: 2023Billy Michael Chelliah Jebaraj, Michael Liew, Felix Seyfried
Blood Advances|October 5, 2024
The dual BCL-2 and BCL-XL inhibitor AZD4320 acts on-target and synergizes with MCL-1 inhibition in B-cell precursor ALLMaren Christiane Wichert, Colin Fortner, Alexandra Niedermayer, et al.
Frontiers in Cell and Developmental Biology|September 27, 2021
MCL-1 Inhibition Overcomes Anti-apoptotic Adaptation to Targeted Therapies in B-Cell Precursor Acute Lymphoblastic LeukemiaAlbert Manzano-Muñoz, Clara Alcon, Pablo Menéndez, et al.
Leukemia|January 15, 2022
Synergistic activity of combined inhibition of anti-apoptotic molecules in B-cell precursor ALLFelix Seyfried, Felix Uli Stirnweiß, Alexandra Niedermayer, et al.
Cell Death & Disease|April 4, 2026
Therapeutic potential of BH3-mimetics and NK cell-mediated immunotherapy in T-ALLColin Fortner, Alexandra Niedermayer, Melina Maria Bäuerle, et al.
Haematologica|March 10, 2018
Leukemia reconstitution <i>in vivo</i> is driven by cells in early cell cycle and low metabolic stateLuca Trentin, Manon Queudeville, Sarah Mirjam Eckhoff, et al.
Leukemia|April 15, 2025
Remission induction in refractory, drug resistant pediatric PICALM::MLLT10+ B-cell acute lymphoblastic leukemia by venetoclaxAlexandra Niedermayer, Jana Stursberg, Anke Katharina Bergmann, et al.
Blood|April 7, 2018
Tight regulation of FOXO1 is essential for maintenance of B-cell precursor acute lymphoblastic leukemiaFan Wang, Salih Demir, Franziska Gehringer, et al.
Blood|May 28, 2017
Central nervous system involvement in acute lymphoblastic leukemia is mediated by vascular endothelial growth factorVera Münch, Luca Trentin, Julia Herzig, et al.
Cell Death & Disease|July 3, 2024
Venetoclax resistance in acute lymphoblastic leukemia is characterized by increased mitochondrial activity and can be overcome by co-targeting oxidative phosphorylationStefanie Enzenmüller, Alexandra Niedermayer, Felix Seyfried, et al.
Pageof 2